WO2004060282A3 - Uses of the snorf207 receptor - Google Patents

Uses of the snorf207 receptor Download PDF

Info

Publication number
WO2004060282A3
WO2004060282A3 PCT/US2003/039465 US0339465W WO2004060282A3 WO 2004060282 A3 WO2004060282 A3 WO 2004060282A3 US 0339465 W US0339465 W US 0339465W WO 2004060282 A3 WO2004060282 A3 WO 2004060282A3
Authority
WO
WIPO (PCT)
Prior art keywords
snorf207
receptor
methods
antagonists
mammalian
Prior art date
Application number
PCT/US2003/039465
Other languages
French (fr)
Other versions
WO2004060282A2 (en
Inventor
Liliana Delgado
Karim Berrada
Roman Artymyshyn
Original Assignee
Synaptic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synaptic Pharma Corp filed Critical Synaptic Pharma Corp
Priority to AU2003300867A priority Critical patent/AU2003300867A1/en
Publication of WO2004060282A2 publication Critical patent/WO2004060282A2/en
Publication of WO2004060282A3 publication Critical patent/WO2004060282A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides methods of treating an abnormality that is linked to the activity of the mammalian SNORF207 receptor, as well as methods of determining binding of compounds to the mammalian SNORF207 receptor, methods of identifying agonists and antagonists of the SNORF207 receptor, and agonists and antagonists so identified.
PCT/US2003/039465 2002-12-19 2003-12-10 Uses of the snorf207 receptor WO2004060282A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003300867A AU2003300867A1 (en) 2002-12-19 2003-12-10 Uses of the snorf207 receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32361102A 2002-12-19 2002-12-19
US10/323,611 2002-12-19

Publications (2)

Publication Number Publication Date
WO2004060282A2 WO2004060282A2 (en) 2004-07-22
WO2004060282A3 true WO2004060282A3 (en) 2005-05-06

Family

ID=32710769

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/039465 WO2004060282A2 (en) 2002-12-19 2003-12-10 Uses of the snorf207 receptor

Country Status (2)

Country Link
AU (1) AU2003300867A1 (en)
WO (1) WO2004060282A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1976509T3 (en) * 2006-01-18 2015-07-31 Evolva Sa Ppar modulators
US8486994B2 (en) 2007-01-18 2013-07-16 Evolva Sa Prodrugs of substituted 1,3-dioxanes and their uses
CN101641009A (en) 2007-01-18 2010-02-03 埃沃尔瓦公司 1 of replacement, 3-dioxane prodrug and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022131A2 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
WO2000050458A1 (en) * 1999-02-26 2000-08-31 Smithkline Beecham Corporation Cloning of a p2y-like 7tm receptor (axor17)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022131A2 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
WO2000050458A1 (en) * 1999-02-26 2000-08-31 Smithkline Beecham Corporation Cloning of a p2y-like 7tm receptor (axor17)

Also Published As

Publication number Publication date
AU2003300867A1 (en) 2004-07-29
AU2003300867A8 (en) 2004-07-29
WO2004060282A2 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
WO2003104410A3 (en) Enzymes
WO2004082621A3 (en) Novel ppar agonists, pharmaceutical compositions and uses thereof
WO2007059300A3 (en) Anti-alk antagonist and agonist antibodies and uses thereof
WO2003094848A3 (en) Nucleic acid-associated proteins
WO2004060282A3 (en) Uses of the snorf207 receptor
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2004009797A3 (en) Protein modification and maintenance molecules
WO2004001008A3 (en) Kinases and phosphatases
WO2004044165A3 (en) Lipid-associated proteins
WO2003104761A3 (en) Measurement of melanocortin peptides and uses thereof
WO2004048550A3 (en) Immune response associated proteins
DE60319989D1 (en) DIAZABICYLONONANE AND DECANDERIVATE AND THEIR USE AS OPIOID RECEPTOR LIGANDS
WO2004050853A3 (en) Uses of the snorf55 receptor
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2003087054A3 (en) Methods for identifying compounds that modulate enzymatic activity
WO2004056861A3 (en) Glycoisoforms of adiponectin and uses thereof
WO2004112729A8 (en) Dual function compounds and uses thereof
WO2002076507A3 (en) Uses of opg ligand to modulate immune responses
WO2004042022A3 (en) Kinases and phosphatases
WO2003100016A3 (en) Protein modification and maintenance molecules
ATE216386T1 (en) KV2.1 ANTAGONISTS
WO2005057223A3 (en) Methods for identifying modulators of active kit tyrosine kinase receptor
WO2003083082A3 (en) Enzymes
WO2003093439A3 (en) Enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP